This issue could also explain why, although IngC treatment had inhibited PKC isoform activities that are involved in migration and invasion in glioma cells, such as PKCα and PKC/PKDμ, it was not able to inhibit cell invasion or migration in either glioma cell tested. This evidence concerns the gene PRKCA and glioma.